Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.

× No keyword cloud information.

9 in total

1. Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.

Authors: Benjamin H Chi; Albert Mwango; Mark J Giganti; Izukanji Sikazwe; Crispin Moyo; Linnaea Schuttner; Lloyd B Mulenga; Carolyn Bolton-Moore; Namwinga T Chintu; Robert Sheneberger; Elizabeth M Stringer; Jeffrey S A Stringer
Journal: J Acquir Immune Defic Syndr Date: 2011-12-15 Impact factor: 3.731

2. A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.

Authors: Nittaya Phanuphak; Jintanat Ananworanich; Nipat Teeratakulpisarn; Tanate Jadwattanakul; Stephen J Kerr; Nitiya Chomchey; Piranun Hongchookiat; Pornpen Mathajittiphun; Suteeraporn Pinyakorn; Patcharawee Rungrojrat; Pairoa Praihirunyakit; Mariana Gerschenson; Praphan Phanuphak; Victor Valcour; Jerome H Kim; Cecilia Shikuma
Journal: Antivir Ther Date: 2012-12-07

3. Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.

Authors: Melissa A Bender; Nagalingeswaran Kumarasamy; Kenneth H Mayer; Bingxia Wang; Rochelle P Walensky; Timothy Flanigan; Bruce R Schackman; Callie A Scott; Zhigang Lu; Kenneth A Freedberg
Journal: Clin Infect Dis Date: 2010-02-01 Impact factor: 9.079

Review 4. A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.

Authors: Michele W Tang; Phyllis J Kanki; Robert W Shafer
Journal: Clin Infect Dis Date: 2012-03 Impact factor: 9.079

5. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.

Authors: Shahin Lockman; Michael Hughes; Fred Sawe; Yu Zheng; James McIntyre; Tsungai Chipato; Aida Asmelash; Mohammed Rassool; Sylvester Kimaiyo; Douglas Shaffer; Mina Hosseinipour; Lerato Mohapi; Francis Ssali; Margret Chibowa; Farida Amod; Elias Halvas; Evelyn Hogg; Beverly Alston-Smith; Laura Smith; Robert Schooley; John Mellors; Judith Currier
Journal: PLoS Med Date: 2012-06-12 Impact factor: 11.069

Review 6. Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.

Authors: Paweł Kawalec; Joanna Kryst; Alicja Mikrut; Andrzej Pilc
Journal: PLoS One Date: 2013-10-07 Impact factor: 3.240

7. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa.

Authors: Kate Shearer; Matthew P Fox; Mhairi Maskew; Rebecca Berhanu; Lawrence Long; Ian Sanne
Journal: PLoS One Date: 2013-08-07 Impact factor: 3.240

8. Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.

Authors: Justen Manasa; Siva Danaviah; Richard Lessells; Muna Elshareef; Frank Tanser; Eduan Wilkinson; Sureshnee Pillay; Hloniphile Mthiyane; Henry Mwambi; Deenan Pillay; Tulio de Oliveira
Journal: AIDS Res Hum Retroviruses Date: 2016-04-20 Impact factor: 2.205

9. Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.

Authors: Kimberly K Scarsi; Geoffrey Eisen; Kristin M Darin; Seema T Meloni; Holly E Rawizza; Eric J Tchetgen Tchetgen; Oche O Agbaji; Daniel I Onwujekwe; Wadzani Gashau; Reuben Nkado; Prosper Okonkwo; Robert L Murphy; Phyllis J Kanki
Journal: Clin Infect Dis Date: 2015-11-10 Impact factor: 9.079

9 in total